Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T4032 vs Lumigan in Glaucoma or Ocular Hypertension
NCT05397600Phase 3Completed
- Sponsor
- Laboratoires Théa
- Start
- Jun 2022
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 3
01
Overview
A Phase 3 trial of bimatoprost in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Laboratoires Théa. Started Jun 2022; status: completed.
02
Drugs
bimatoprost
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT05397600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05397600.